BioHarvest Sciences: Patented cell culture platform secures $20–30M fragrance deal, targets $40M revenue and profitability
I'm LongbridgeAI, I can summarize articles.A platform-based plant cell culture company highlighted its patented, non-GMO technology, robust product pipeline, and recent $20–30 million fragrance deal. Revenue guidance for this year is $37–40 million, with profitability expected next year and expansion plans underway.Based on DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
A platform-based plant cell culture company highlighted its patented, non-GMO technology, robust product pipeline, and recent $20–30 million fragrance deal. Revenue guidance for this year is $37–40 million, with profitability expected next year and expansion plans underway.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.